Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-04T08:13:57.053Z.
Calculation as of: 2026-10-04T08:13:57.053Z.
Quote observation: 2026-10-02T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 57b60877cfd9fa538daf0f8b567712afefe99729f4ad10ceac90ec610a13b4bd
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Shoulder Innovations, Inc.
Market Cap
$394.23M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$458.62M
Operating Cash Flow Yield
6.43%
TTM Avg
6.71%
3Y Avg
7.00%
5Y Avg
5.83%
Market Cap
$474.59M
Operating Cash Flow Yield
4.65%
TTM Avg
5.10%
3Y Avg
4.22%
5Y Avg
4.07%
Market Cap
$41.86M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Operating Cash Flow Yield
26.04%
TTM Avg
24.46%
3Y Avg
20.42%
5Y Avg
14.91%
Market Cap
$1.71B
Operating Cash Flow Yield
N/A
TTM Avg
9.83%
3Y Avg
9.83%
5Y Avg
9.83%
Market Cap
$1.74B
Operating Cash Flow Yield
18.37%
TTM Avg
11.24%
3Y Avg
10.44%
5Y Avg
9.15%
Market Cap
$1.90B
Operating Cash Flow Yield
9.59%
TTM Avg
8.54%
3Y Avg
14.04%
5Y Avg
13.43%
Market Cap
$2.02B
Operating Cash Flow Yield
7.76%
TTM Avg
7.37%
3Y Avg
3.47%
5Y Avg
2.92%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $394.23M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $458.62M | 6.43% | 6.71% | 7.00% | 5.83% |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | 4.65% | 5.10% | 4.22% | 4.07% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.86M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | 26.04% | 24.46% | 20.42% | 14.91% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | N/A | 9.83% | 9.83% | 9.83% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 18.37% | 11.24% | 10.44% | 9.15% |
| Fortrea Holdings Inc. (FTRE)vs › | $1.90B | 9.59% | 8.54% | 14.04% | 13.43% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.02B | 7.76% | 7.37% | 3.47% | 2.92% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
